Rafael Holdings Reports Fiscal Year 2026 Financial Results
The Newark-based company posted a $29.6 million net loss while facing questions regarding its future as a going concern.
Live Poll
Do you trust biotechnology companies to succeed despite recent financial losses and failed clinical trials?